Online citations, reference lists, and bibliographies.
← Back to Search

Nanoparticles With CD44 Targeting And ROS Triggering Properties As Effective In Vivo Antigen Delivery System.

X. Liang, X. Li, Jianwei Duan, Youlu Chen, X. Wang, L. Pang, D. Kong, B. Song, Chen Li, J. Yang
Published 2018 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Currently, development of subunit vaccine based on recombinant antigens or peptides has gradually become an important alternative option for traditional vaccine. However, induction of potent immune response with desired efficacy remains a major challenge. The nanoparticle-based antigen delivery system has been considered a potential carrier system to improve the efficacy of subunit vaccine. In the present study, we have designed an immune-stimulatory delivery system by conjugating three-armed PLGA to PEG via the peroxalate ester bond which is sensitive to hydrogen peroxide (H2O2), a major reactive oxygen species (ROS). Hyaluronic acid (HA), a ligand for CD44 receptors was also modified onto the outer shell of the 3s-PLGA-PEG nanoparticles to promote immune cell uptake. For in vitro and in vivo immune response assessment, a model antigen ovalbumin (OVA) was enclosed within the core of the 3s-PLGA-PEG nanoparticles to form 3s-PLGA-PO-PEG/HA nanoparticles (PHO NPs). Our results showed that the PHO NPs enhanced dendritic cell maturation, antigen uptake, and antigen presentation in vitro, likely due to enhanced lysosomal escape. In vivo experiments further revealed that the PHO nanovaccine robustly promoted OVA-specific antibody production and T cell response accompanied by modest stimulation of memory T cells. In summary, the ROS-responsive PHO NPs with modified HA may be an effective vehicle antigen delivery system to promote antigen-induced immune response.
This paper references
10.1039/c1nr10166h
The role of surface charge density in cationic liposome-promoted dendritic cell maturation and vaccine-induced immune responses.
Yifan Ma (2011)
10.1016/j.molimm.2015.09.011
PLGA (85:15) nanoparticle based delivery of rL7/L12 ribosomal protein in mice protects against Brucella abortus 544 infection: A promising alternate to traditional adjuvants.
D. Singh (2015)
10.1016/S0142-9612(03)00467-8
Hyaluronan microspheres for sustained gene delivery and site-specific targeting.
Y. H. Yun (2004)
10.1021/acs.molpharmaceut.7b00320
Chitosan/Hyaluronic Acid Nanoparticles: Rational Design Revisited for RNA Delivery.
E. Lallana (2017)
10.2147/IJN.S119446
Synthesis of three-arm block copolymer poly(lactic-co-glycolic acid)–poly(ethylene glycol) with oxalyl chloride and its application in hydrophobic drug delivery
X. Zhu (2016)
10.1152/physrev.00052.2009
Hyaluronan as an immune regulator in human diseases.
D. Jiang (2011)
10.1096/fasebj.6.14.1385241
A two‐signal model for regulation of immunoglobulin isotype switching
J. Purkerson (1992)
10.1038/nrd3499
Bio-inspired, bioengineered and biomimetic drug delivery carriers
Jin-Wook Yoo (2011)
10.1371/journal.ppat.1005895
The Breadth of Synthetic Long Peptide Vaccine-Induced CD8+ T Cell Responses Determines the Efficacy against Mouse Cytomegalovirus Infection
E. Panagioti (2016)
10.1021/acsami.7b08312
Bilayered Nanoparticles with Sequential Release of VEGF Gene and Paclitaxel for Restenosis Inhibition in Atherosclerosis.
X. Zhu (2017)
10.1016/J.VACCINE.2005.08.111
Very small size proteoliposomes derived from Neisseria meningitidis: An effective adjuvant for generation of CTL responses to peptide and protein antigens.
C. Mesa (2006)
10.1038/nnano.2007.223
Immunological properties of engineered nanomaterials
M. Dobrovolskaia (2007)
10.1002/eji.200737984
Nanoparticles target distinct dendritic cell populations according to their size
V. Manolova (2008)
10.1016/j.jconrel.2017.08.009
Lymph node targeting strategies to improve vaccination efficacy
H. Jiang (2017)
10.1016/j.addr.2009.06.001
Recent advances in the use of cell-penetrating peptides for medical and biological applications.
S. Fonseca (2009)
10.1074/jbc.M414048200
Role of CD44 in Epithelial Wound Repair
S. Kikuchi (2005)
10.1038/35100512
Cross-presentation in viral immunity and self-tolerance
W. Heath (2001)
10.1021/nn202070n
Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
K. Choi (2011)
10.1016/j.jconrel.2017.04.020
Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy
Chuangnian Zhang (2017)
- elicited antitumor immunity by enhancing TLR 3 - IRF 3 signaling and type I interferons in dendritic cells
W. R. Heath (2012)
10.1016/j.biomaterials.2008.02.015
The effect of poly(D,L-lactide-co-glycolide) microparticles with polyelectrolyte self-assembled multilayer surfaces on the cross-presentation of exogenous antigens.
Y. Yang (2008)
10.1016/j.jconrel.2016.01.050
Immune responses to vaccines delivered by encapsulation into and/or adsorption onto cationic lipid-PLGA hybrid nanoparticles.
Lanxia Liu (2016)
10.1056/NEJMOA022749
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.
M. Harisinghani (2003)
10.1128/IAI.73.11.7759-7764.2005
Memory T Lymphocytes Generated by Mycobacterium bovis BCG Vaccination Reside within a CD4 CD44lo CD62 Ligandhi Population
A. Kipnis (2005)
10.1161/JAHA.116.003697
Hydrogen Peroxide‐Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury
Soochan Bae (2016)
10.1016/j.vaccine.2012.05.027
Toll-like receptor 3 agonist complexed with cationic liposome augments vaccine-elicited antitumor immunity by enhancing TLR3-IRF3 signaling and type I interferons in dendritic cells.
C. Wang (2012)
10.1021/acs.molpharmaceut.7b00015
A Light Responsive Nanoparticle-Based Delivery System Using Pheophorbide A Graft Polyethylenimine for Dendritic Cell-Based Cancer Immunotherapy.
Chuangnian Zhang (2017)
10.1021/acsami.7b06879
EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo.
J. Chen (2017)
10.1158/1078-0432.CCR-11-2938
Best Practices in Cancer Nanotechnology: Perspective from NCI Nanotechnology Alliance
W. Zamboni (2012)
10.1021/acs.molpharmaceut.6b00969
Effects of Membrane PEGylation on Entry and Location of Antifungal Drug Itraconazole and Their Pharmacological Implications.
Monika Dzieciuch-Rojek (2017)
10.1007/s00418-004-0648-2
Actin microdomains on endothelial cells: association with CD44, ERM proteins, and signaling molecules during quiescence and wound healing
P. V. Jensen (2004)
Toll - like receptor 3 agonist complexed with cationic liposome augments
C. Wang
10.1021/mp500589c
Rapid and Persistent Delivery of Antigen by Lymph Node Targeting PRINT Nanoparticle Vaccine Carrier To Promote Humoral Immunity.
S. Mueller (2015)
10.1016/j.biomaterials.2010.11.033
Reduction of oxidative stress by p-hydroxybenzyl alcohol-containing biodegradable polyoxalate nanoparticulate antioxidant.
S. Kim (2011)



This paper is referenced by
10.1039/c9ob00859d
H2O2-responsive polymeric micelles with a benzil moiety for efficient DOX delivery and AIE imaging.
Yan-Dong Dai (2019)
10.1002/open.201900126
Mannose‐Modified Multi‐Walled Carbon Nanotubes as a Delivery Nanovector Optimizing the Antigen Presentation of Dendritic Cells
Z. Dong (2019)
10.1002/anie.201807595
Hybrid Nanoreactors: Enabling an Off-the-Shelf Strategy for Concurrently Enhanced Chemo-immunotherapy.
Yannan Yang (2018)
10.3389/fimmu.2020.00333
Anti-Dengue ED3 Long-Term Immune Response With T-Cell Memory Generated Using Solubility Controlling Peptide Tags
M. M. Islam (2020)
10.1088/1748-605X/ab9bb2
Reactive oxygen species-sensitive nanophotosensitizers of aminophenyl boronic acid pinacol ester conjugated chitosan-g-methoxy poly(ethylene glycol) copolymer for photodynamic treatment of cancer.
Young-Il Jeong (2020)
10.1002/adma.201904040
Exosomes and Nanoengineering: A Match Made for Precision Therapeutics.
P. Tran (2019)
10.1016/j.carbpol.2020.116204
Recent advantage of hyaluronic acid for anti-cancer application: a review of "3S" transition approach.
W. Zhong (2020)
10.1002/adhm.201801320
Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy.
E. Lee (2019)
10.1007/978-981-15-5120-8
Cancer Stem Cells: New Horizons in Cancer Therapies
Surajit Pathak (2020)
10.1002/smll.201900262
Nanoparticle-Based Nanomedicines to Promote Cancer Immunotherapy: Recent Advances and Future Directions.
J. Liu (2019)
10.1111/raq.12518
Developing oral nanovaccines for fish: a modern trend to fight infectious diseases
C. Angulo (2020)
Semantic Scholar Logo Some data provided by SemanticScholar